Online CME / CE Programs
Hematology
Transthyretin amyloidosis (ATTR): Prompt diagnosis, contemporary management strategies, and their impact on patient outcomes (Kourosh Rezania MD) Released: 12/29/2021 - Expires: 12/29/2023 (1 hr CE) ACCME ACPE MOC
Beta thalassemia: best practices and novel approaches in its recognition and treatment (Cheryl Mensah MD) Released: 11/06/2021 - Expires: 11/06/2023 (1 hr CE) ACCME ACPE MOC
Biosimilars in the treatment of malignancies and supportive care (Elizabeta Popa MD) Released: 05/13/2021 - Expires: 05/13/2023 (1 hr CE) ACCME ACPE MOC
von Willebrand's disease: an in-depth review of management strategies (Hillary Maitland MD, MS) Released: 04/27/2021 - Expires: 04/27/2023 (1 hr CE) ACCME ACPE MOC
von Willebrand's disease: therapeutic updates and optimizing treatment (Rajiv Pruthi MD) Released: 03/07/2021 - Expires: 03/07/2023 (1 hr CE) ACCME ACPE MOC
Contemporary approaches to advanced diffuse large B-cell lymphoma (DLBCL) (Carla Casulo MD) Released: 12/22/2020 - Expires: 12/22/2022 (0.75 hr CE) ACCME ACPE MOC
Treating Oncology Patients During COVID-19 (Elizabeta Popa MD) Released: 09/22/2020 - Expires: 09/22/2022 (0.75 hr CME) ACCME MOC
Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Updates from the American Society of Hematology (ASH) 2019 annual meeting (Satheesh Chonat MD) Released: 08/30/2020 - Expires: 08/30/2022 (0.75 hr CE) ACCME ACPE
Updates in chronic lymphocytic leukemia (CLL) treatment paradigms (Matthew Davids MD, MMSc) Released: 07/21/2021 - Expires: 07/21/2022 (1 hr CE) ACCME ACPE MOC
Managing Cardiovascular Risk in Women Updated Guidance (NATF) (Multiple Faculty ) Released: 01/13/2021 - Expires: 07/13/2022 (2 hr CE) ACCME ACPE MOC
Transthyretin amyloidosis (ATTR) and its complications: Optimizing management strategies (Robert Chilton MD) Released: 06/13/2020 - Expires: 06/13/2022 (0.75 hr CE) ACCME ACPE
Hemophilia B: Optimizing Pharmacotherapeutic Management Strategies (Lisa Boggio MD) Released: 06/10/2020 - Expires: 06/10/2022 (1 hr CE) ACCME ACPE MOC
Hemophilia A: Optimizing Pharmacotherapeutic Management Strategies (Lisa Boggio MD) Released: 06/06/2020 - Expires: 06/06/2022 (1 hr CE) ACCME ACPE MOC
Best practices and emerging therapy in relapsed or refractory multiple myeloma (Monique Hartley-Brown MD) Released: 05/27/2021 - Expires: 05/27/2022 (1.5 hr CE) ACCME ACPE MOC
Cold agglutinin disease (CAD): Updates from the American Society of Hematology (ASH) 2019 annual meeting (Adrienne Phillips MD) Released: 02/21/2020 - Expires: 02/21/2022 (1 hr CE) ACCME ACPE
Atypical hemolytic uremic syndrome (aHUS): Therapeutic updates and optimizing treatment (Ramy Hanna MD) Released: 07/10/2019 - CME EXPIRED: 07/10/2021
Multiple Myeloma (MM): Updates from 23rd Annual Congress of EHA (EHA 2018) (Shaji Kumar MD) Released: 04/25/2019 - CME EXPIRED: 04/25/2021
Hemophilia B: Updates from 2018 American Society of Hematology Annual Meeting (ASH 2018) (Christopher Walsh MD) Released: 03/05/2019 - CME EXPIRED: 03/05/2021
Hemophilia A: Updates from 2018 American Society of Hematology Annual Meeting (ASH 2018) (Christopher Walsh MD) Released: 03/04/2019 - CME EXPIRED: 03/04/2021
Congenital Thrombotic Thrombocytopenic Purpura (cTTP): Therapeutic Updates, Best Practices, and Emerging Therapies (Ilene Weitz MD) Released: 10/02/2018 - CME EXPIRED: 10/02/2020
Multiple Myeloma (MM): Highlights from the American Society for Clinical Oncology (ASCO) 2018 (Ravi Vij MD MBA) Released: 07/19/2018 - CME EXPIRED: 07/19/2020
Hemophilia B: Therapeutic Updates, Emerging Therapies, and Barriers to Care (Christopher Walsh MD) Released: 05/08/2018 - CME EXPIRED: 05/08/2020
Hemophilia A: Therapeutic Updates, Emerging Therapies, and Barriers to Care (Doris Quon MD PhD) Released: 03/17/2018 - CME EXPIRED: 03/17/2020
Diffuse Large B-Cell Lymphoma (DLBCL): Therapeutic Updates and Best Practices (Jonathan Kolitz MD) Released: 03/16/2018 - CME EXPIRED: 03/16/2020
Advancing Treatment Strategies in Multiple Myeloma (MM) Drug Therapy (Ravi Vij MD MBA) Released: 11/02/2017 - CME EXPIRED: 11/02/2019